cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
DA003052 | .a | 88 to 433 | 128 to 473 | capped | 472/472 (100 %) | 0 diff (100 %id) | |||
AA249583 | .a | -10 to 240 | 1 to 247 | 247/250 (98 %) | 9 diff (96.4 %id) | ||||
AA249666 | .a | -10 to 194 | 1 to 204 | 204/204 (100 %) | 9 diff (95.6 %id) | ||||
AA312280 | .a | 1 to 430 | 7 to 437 | 437/437 (100 %) | 2 diff (99.6 %id) | ||||
AF017790 | .a | 10 to 2078 | 18 to 2086 | exact | AAA | 2069/2086 (99 %) | 6 diff (99.8 %id) | ||
AK289396 | .a | 88 to 2085 | 128 to 2125 | exact | 2125/2125 (100 %) | 0 diff (100 %id) | |||
AK313184 | .a | 88 to 2025 | 126 to 2063 | exact | 2063/2063 (100 %) | 2 diff (100.0 %id) | |||
DA019356 | .a | 88 to 492 | 147 to 551 | capped | 550/550 (100 %) | 0 diff (100 %id) | |||
DA022482 | .a | 88 to 542 | 128 to 582 | capped | 581/581 (100 %) | 0 diff (100 %id) | |||
DA034022 | .a | 88 to 534 | 129 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | |||
AW362778 | colon | .a | 1659 to 1981 | 323 to 1 | 323/323 (100 %) | 1 diff (99.7 %id) | |||
AW955129 | .a | 1 to 647 | 6 to 652 | 652/655 (99 %) | 10 diff (98.5 %id) | ||||
BC035617 | Brain, adult medulla | .a | 88 to 2085 | 105 to 2102 | exact | tiling clone, available from MGC, AAA | 2102/2102 (100 %) | 0 diff (100 %id) | |
BE940500 | uterus_tumor | .a | 88 to 420 | 129 to 461 | 434/461 (94 %) | 8 diff (98.3 %id) | |||
BF082771 | breast | .a | 1659 to 1992 | 336 to 3 | 334/336 (99 %) | 1 diff (99.8 %id) | |||
BF084870 | lung_normal | .a | 1658 to 1988 | 334 to 4 | 331/334 (99 %) | 5 diff (98.6 %id) | |||
BF899120 | marrow | .a | 232 to 359 | 17 to 144 | 128/144 (88 %) | 7 diff (95.2 %id) | |||
BF994346 | placenta_normal | .a | 1169 to 1659 | 22 to 511 | 490/536 (91 %) | 24 diff (95.6 %id) | |||
DA043783 | bladder | .a | 88 to 531 | 128 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DA050103 | .a | 1 to 547 | 5 to 551 | capped | 550/550 (100 %) | 2 diff (99.7 %id) | |||
DA051790 | .a | 50 to 640 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | |||
BQ307283 | breast | .a | 527 to 1079 | 1 to 549 | 549/559 (98 %) | 10 diff (98.3 %id) | |||
BQ307306 | breast | .a | 572 to 1090 | 518 to 3 | 516/519 (99 %) | 5 diff (99.1 %id) | |||
BX284007 | skin, squamous cell carcinoma | .a | 959 to 1444 | 1 to 486 | 486/486 (100 %) | 0 diff (100 %id) | |||
CB150849 | cervix, Uterine | .a | 759 to 1352 | 1 to 594 | 594/594 (100 %) | 6 diff (99.0 %id) | |||
DA419915 | cord Blood | .a | 1 to 565 | 7 to 572 | capped | 571/571 (100 %) | 1 diff (99.9 %id) | ||
CN294232 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 1499 to 2085 | 1 to 587 | AAA | 587/587 (100 %) | 1 diff (99.9 %id) | ||
CN294233 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 32 to 614 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
CN294234 | embryonic stem cells, DMSO-treated H9 cellline | .a | 88 to 639 | 110 to 661 | 661/661 (100 %) | 1 diff (99.9 %id) | |||
CN294235 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 88 to 613 | 112 to 637 | 637/637 (100 %) | 2 diff (99.7 %id) | |||
CN294236 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 324 to 735 | 1 to 412 | 412/418 (98 %) | 4 diff (99.1 %id) | |||
CN294237 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1137 to 1861 | 1 to 725 | 725/725 (100 %) | 0 diff (100 %id) | |||
CN294238 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 13 to 403 | 1 to 391 | 391/391 (100 %) | 3 diff (99.3 %id) | |||
CN294239 | embryonic stem cells, DMSO-treated H9 cellline | .a | 1 to 537 | 5 to 541 | 541/541 (100 %) | 1 diff (99.9 %id) | |||
CN294240 | embryonic stem cells, DMSO-treated H9 cellline | .a | 88 to 537 | 107 to 556 | 554/556 (99 %) | 7 diff (98.8 %id) | |||
CN294241 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 88 to 607 | 163 to 684 | 667/684 (97 %) | 8 diff (98.9 %id) | |||
CN294242 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 501 to 1222 | 1 to 725 | tiling clone, | 725/725 (100 %) | 6 diff (99.2 %id) | ||
CN294243 | embryonic stem cells, DMSO-treated H9 cellline | .a | 88 to 590 | 116 to 618 | 618/618 (100 %) | 1 diff (99.9 %id) | |||
CN294244 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1 to 516 | 5 to 520 | 520/520 (100 %) | 2 diff (99.7 %id) | |||
CN294245 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1 to 761 | 7 to 770 | 770/770 (100 %) | 6 diff (99.3 %id) | |||
CR609890 | fetal liver | .a | 27 to 2044 | 1 to 2018 | exact | 2018/2018 (100 %) | 0 diff (100 %id) | ||
BX353230 | Neuroblastoma Cot 25-normalized | .a | 1 to 954 | 6 to 955 | 955/958 (99 %) | 24 diff (97.5 %id) | |||
BX372554 | Neuroblastoma Cot 25-normalized | .a | 1652 to 2050 | 404 to 5 | 400/494 (80 %) | 26 diff (94.8 %id) | |||
AL527307 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 975 to 2051 | 1066 to 1 | 1066/1072 (99 %) | 28 diff (97.4 %id) | |||
AL527360 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1 to 960 | 6 to 959 | 959/965 (99 %) | 15 diff (98.5 %id) | |||
BX333981 | Neuroblastoma Cot 50-normalized | .a | 1405 to 2062 | 657 to 1 | 657/657 (100 %) | 25 diff (96.2 %id) | |||
BX351284 | Neuroblastoma Cot 50-normalized | .a | 1468 to 2033 | 567 to 1 | 567/630 (90 %) | 15 diff (97.7 %id) | |||
AL583241 | B cells from Burkitt lymphoma | .a | 1183 to 2049 | 887 to 1 | 887/935 (94 %) | 50 diff (94.7 %id) | |||
AL531914 | brain, fetal liver, Liver, neuroblastoma cells | .a | 1110 to 2044 | 935 to 1 | 935/935 (100 %) | 3 diff (99.7 %id) | |||
AL531915 | brain, fetal liver, Liver, neuroblastoma cells | .a | 27 to 1053 | 1 to 1020 | 1020/1058 (96 %) | 10 diff (99.1 %id) | |||
BX431751 | fetal liver, Liver | .a | 901 to 1782 | 1 to 876 | 876/876 (100 %) | 11 diff (98.8 %id) | |||
DA445269 | tongue, tumor tissue | .a | 88 to 500 | 128 to 540 | capped | 539/539 (100 %) | 0 diff (100 %id) | ||
CV030676 | mixed | .a | 97 to 716 | 1 to 619 | 619/619 (100 %) | 1 diff (99.9 %id) | |||
CV363738 | colon | .b | 1116 to 1575 | 1 to 460 | tiling clone, | 460/472 (97 %) | 15 diff (96.9 %id) | ||
DA473757 | .a | 88 to 535 | 128 to 576 | capped | 575/575 (100 %) | 1 diff (99.9 %id) | |||
DA479788 | .a | 1 to 537 | 4 to 540 | capped | 539/539 (100 %) | 1 diff (99.9 %id) | |||
DA480755 | .a | 88 to 516 | 128 to 556 | capped | 555/555 (100 %) | 0 diff (100 %id) | |||
AL711170 | human skeletal muscle | .a | 88 to 506 | 151 to 569 | 569/569 (100 %) | 1 diff (99.9 %id) | |||
AL710845 | human skeletal muscle | .a | 88 to 636 | 101 to 649 | 649/649 (100 %) | 1 diff (99.9 %id) | |||
DN912296 | .a | 1012 to 1642 | 631 to 1 | 631/631 (100 %) | 3 diff (99.6 %id) | ||||
DN912297 | .a | 88 to 634 | 104 to 651 | 651/651 (100 %) | 1 diff (99.9 %id) | ||||
DN918556 | .g-u | 38 to 612 | 575 to 1 | tiling clone, | 575/575 (100 %) | 3 diff (99.5 %id) | |||
DN918557 | .g-u | 1 to 583 | 1 to 580 | exact | tiling clone, | 580/580 (100 %) | 6 diff (99.0 %id) | ||
DW442688 | Liver | .a | 54 to 269 | 17 to 232 | 216/233 (92 %) | 9 diff (96.2 %id) | |||
EH322556 | .a | 164 to 257 | 1 to 94 | 94/94 (100 %) | 0 diff (100 %id) | ||||
AV718407 | corresponding non cancerous liver tissue | .a | 1607 to 2065 | 459 to 1 | Submitted on the opposite strand | 459/459 (100 %) | 1 diff (99.8 %id) | ||
DB451073 | testis | .a | 88 to 440 | 122 to 474 | 474/474 (100 %) | 1 diff (99.8 %id) | |||
AW069561 | bone marrow stroma | .a | 1613 to 2085 | 491 to 19 | AAA | 473/473 (100 %) | 1 diff (99.8 %id) | ||
DA551982 | .a | 1 to 509 | 2 to 510 | capped | 509/509 (100 %) | 0 diff (100 %id) | |||
BP239153 | Liver | .a | 88 to 603 | 105 to 620 | 620/620 (100 %) | 5 diff (99.2 %id) | |||
AU099103 | .a | 88 to 227 | 161 to 300 | 300/300 (100 %) | 7 diff (97.7 %id) | ||||
BP242960 | Liver | .a | 88 to 499 | 161 to 572 | 572/572 (100 %) | 7 diff (98.8 %id) | |||
BJ991538 | hepatoblastoma | .a | 1 to 580 | 6 to 585 | 585/585 (100 %) | 2 diff (99.7 %id) | |||
BJ991539 | hepatoblastoma | .a | 1544 to 2083 | 540 to 1 | 540/540 (100 %) | 0 diff (100 %id) | |||
R92253 | liver and spleen | .a | 46 to 401 | 1 to 358 | 358/441 (81 %) | 6 diff (98.7 %id) | |||
R94766 | liver and spleen | .a | 1690 to 2080 | 399 to 1 | 397/416 (95 %) | 13 diff (96.9 %id) | |||
W72679 | heart | .f | 236 to 632 | 411 to 7 | tiling clone, fully sequenced, | 405/411 (98 %) | 6 diff (98.6 %id) | ||
W77785 | heart | .f | 1 to 266 | 1 to 264 | M27X L28W | tiling clone, fully sequenced, | 264/264 (100 %) | 2 diff (99.3 %id) | |
AA700427 | liver and spleen | .a | 532 to 946 | 414 to 1 | 414/414 (100 %) | 5 diff (98.8 %id) | |||
AA211359 | .a | 1716 to 2084 | 369 to 1 | 369/374 (98 %) | 1 diff (99.8 %id) | ||||
AA188980 | .a | 1211 to 1458 | 1 to 251 | 251/258 (97 %) | 7 diff (97.3 %id) | ||||
AA188981 | .a | 1833 to 2086 | 256 to 3 | 254/258 (98 %) | 1 diff (99.7 %id) | ||||
AA189047 | .a | 1211 to 1498 | 1 to 292 | 292/293 (99 %) | 13 diff (95.6 %id) | ||||
AA492580 | thyroid | .a | 1828 to 2086 | 265 to 7 | 259/265 (97 %) | 0 diff (100 %id) | |||
AA639709 | breast | .a | 1666 to 2085 | 420 to 1 | 420/420 (100 %) | 0 diff (100 %id) | |||
AA857356 | pharynx, squamous cell carcinoma | .a | 1648 to 2081 | 434 to 1 | 434/434 (100 %) | 0 diff (100 %id) | |||
AA878068 | pharynx, squamous cell carcinoma | .a | 1564 to 2081 | 518 to 2 | 517/518 (99 %) | 8 diff (98.5 %id) | |||
AI380253 | B-cell, chronic lymphotic leukemia | .a | 1799 to 2084 | 286 to 1 | 286/286 (100 %) | 4 diff (98.7 %id) | |||
AI913466 | adenocarcinoma, Pancreas | .a | 1579 to 2084 | 511 to 6 | 506/511 (99 %) | 0 diff (100 %id) | |||
AI660156 | thymus, pooled | .a | 1558 to 2086 | 535 to 9 | 527/535 (98 %) | 5 diff (99.1 %id) | |||
AI866885 | adenocarcinoma, Pancreas | .a | 1705 to 2084 | 380 to 1 | 380/380 (100 %) | 0 diff (100 %id) | |||
AI979323 | pooled germ cell tumors | .a | 1770 to 2078 | 309 to 1 | 309/309 (100 %) | 1 diff (99.7 %id) | |||
AW449014 | .a | 1737 to 2078 | 359 to 18 | AAA | 342/352 (97 %) | 1 diff (99.8 %id) | |||
AW573107 | pooled | .a | 1557 to 1936 | 380 to 1 | 380/406 (93 %) | 12 diff (97.1 %id) | |||
BE672102 | pooled germ cell tumors | .a | 1770 to 2078 | 309 to 1 | 309/309 (100 %) | 2 diff (99.4 %id) | |||
BF589484 | Prostate | .a | 1498 to 1837 | 343 to 4 | 340/343 (99 %) | 22 diff (93.6 %id) | |||
BE857720 | Prostate | .a | 1435 to 2081 | 652 to 6 | 647/652 (99 %) | 1 diff (99.9 %id) | |||
BE543964 | cervical carcinoma cell line, cervix | .h | 1 to 290 | 1 to 285 | Y7I P8L F9L A10H L11Y ... | tiling clone, | 285/285 (100 %) | 6 diff (97.9 %id) | |
BF447144 | Prostate | .a | 1693 to 2085 | 393 to 1 | 393/393 (100 %) | 0 diff (100 %id) | |||
BC010171 | Lymph, Burkitt lymphoma | .a | 88 to 963 | 102 to 976 | available from MGC, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 976/978 (99 %) | 6 diff (99.4 %id) | |
BE561023 | Burkitt lymphoma, lymph | .a | 6 to 773 | 1 to 775 | available from MGC, | 775/859 (90 %) | 18 diff (98.0 %id) | ||
BE566742 | bladder, carcinoma, cell line | .a | 88 to 497 | 122 to 537 | 537/537 (100 %) | 21 diff (96.1 %id) | |||
BE565202 | bladder, carcinoma, cell line | .a | 88 to 719 | 106 to 751 | 651/792 (82 %) | 25 diff (96.9 %id) | |||
BE564344 | bladder, carcinoma, cell line | .a | 88 to 548 | 124 to 581 | 581/891 (65 %) | 9 diff (99.0 %id) | |||
BF038467 | adenocarcinoma, ovary | .a | 970 to 1759 | 1 to 805 | 805/1072 (75 %) | 47 diff (95.7 %id) | |||
BE889796 | leiomyosarcoma, uterus | .a | 996 to 1735 | 1 to 741 | 741/808 (91 %) | 12 diff (98.6 %id) | |||
BE903220 | choriocarcinoma, placenta | .a | 88 to 688 | 165 to 765 | 743/766 (96 %) | 10 diff (98.7 %id) | |||
BC005239 | Bladder, carcinoma | .a | 88 to 1657 | 144 to 1713 | available from MGC, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 1713/1726 (99 %) | 7 diff (99.6 %id) | |
BF029347 | bladder, carcinoma, cell line | .a | 88 to 660 | 124 to 694 | available from MGC, | 694/817 (84 %) | 38 diff (95.4 %id) | ||
BF687621 | brain, glioblastoma | .a | 742 to 1406 | 1 to 651 | 653/800 (81 %) | 34 diff (95.8 %id) | |||
BF540908 | hypernephroma, Kidney | .a | 898 to 1439 | 1 to 540 | 540/643 (83 %) | 9 diff (98.7 %id) | |||
BF246242 | brain, glioblastoma | .a | 1028 to 1557 | 1 to 538 | 538/831 (64 %) | 31 diff (96.3 %id) | |||
BF246890 | brain, glioblastoma | .a | 88 to 440 | 128 to 481 | 481/481 (100 %) | 9 diff (98.2 %id) | |||
BF244797 | brain, glioblastoma | .a | 88 to 674 | 104 to 683 | 683/865 (78 %) | 23 diff (97.4 %id) | |||
BF219086 | brain, glioblastoma | .a | 88 to 642 | 104 to 664 | 660/782 (84 %) | 20 diff (97.5 %id) | |||
BF218992 | brain, glioblastoma | .a | 870 to 1552 | 1 to 668 | 668/850 (78 %) | 24 diff (97.2 %id) | |||
BF665251 | brain, primitive neuroectoderm | .a | 1 to 678 | 6 to 688 | 688/836 (82 %) | 23 diff (97.3 %id) | |||
BF666100 | brain, primitive neuroectoderm | .a | 1 to 519 | 5 to 548 | 545/548 (99 %) | 37 diff (93.3 %id) | |||
BF667950 | brain, primitive neuroectoderm | .a | 88 to 666 | 104 to 683 | 683/827 (82 %) | 16 diff (98.1 %id) | |||
BF700934 | brain, primitive neuroectoderm | .a | 4 to 631 | 1 to 624 | 624/871 (71 %) | 22 diff (97.5 %id) | |||
BF576929 | muscle (skeletal) | .d | 1 to 696 | 1 to 691 | L143* | tiling clone, | 691/803 (86 %) | 19 diff (97.7 %id) | |
BF684028 | leiomyosarcoma cell line, uterus | .a | 17 to 763 | 1 to 741 | 741/919 (80 %) | 15 diff (98.4 %id) | |||
BF976962 | melanotic melanoma, high MDR, skin | .a | 1 to 678 | 4 to 689 | 689/710 (97 %) | 24 diff (96.7 %id) | |||
BF977553 | melanotic melanoma, high MDR, skin | .a | 88 to 584 | 123 to 630 | 630/816 (77 %) | 26 diff (96.9 %id) | |||
BF978548 | melanotic melanoma, high MDR, skin | .a | 746 to 1491 | 1 to 750 | 750/750 (100 %) | 10 diff (98.7 %id) | |||
BF984727 | duodenal adenocarcinoma, cell line, small intestine | .a | 591 to 1379 | 1 to 787 | 788/934 (84 %) | 27 diff (97.2 %id) | |||
BG257162 | embryonal carcinoma, cell line, testis | .a | 669 to 1315 | 1 to 647 | 647/970 (66 %) | 11 diff (98.9 %id) | |||
BG403284 | bladder, transitional cell papilloma, cell line | .a | 266 to 859 | 5 to 595 | 591/598 (98 %) | 2 diff (99.7 %id) | |||
BG500282 | adenocarcinoma, Prostate | .a | 88 to 592 | 138 to 643 | 643/643 (100 %) | 5 diff (99.3 %id) | |||
BG531886 | embryonal carcinoma, testis | .a | 88 to 576 | 151 to 633 | 631/906 (69 %) | 15 diff (98.4 %id) | |||
BG532554 | embryonal carcinoma, testis | .a | 88 to 657 | 175 to 756 | 756/756 (100 %) | 26 diff (96.6 %id) | |||
BG679506 | skin, squamous cell carcinoma | .a | 958 to 1784 | 1 to 831 | 831/838 (99 %) | 15 diff (98.3 %id) | |||
BG624100 | placenta | .c | 1 to 691 | 1 to 686 | W5G I6F L7V P9R E10R ... | tiling clone, | 686/785 (87 %) | 29 diff (96.4 %id) | |
BG612856 | embryonal carcinoma, testis | .a | 4 to 502 | 1 to 500 | 500/503 (99 %) | 6 diff (98.9 %id) | |||
BI087094 | cervix | .a | 1087 to 1878 | 1 to 797 | 797/797 (100 %) | 10 diff (98.8 %id) | |||
BI093871 | cervix | .a | -11 to 765 | 1 to 775 | 775/839 (92 %) | 16 diff (98.1 %id) | |||
BI260526 | cervical carcinoma cell line, cervix | .a | 1016 to 1817 | 1 to 804 | 804/805 (99 %) | 15 diff (98.2 %id) | |||
BI825656 | brain, medulla | .a | 88 to 765 | 104 to 790 | 790/1012 (78 %) | 18 diff (98.3 %id) | |||
BI861865 | breast, mammary adenocarcinoma, cell line | .a | 1351 to 1648 | 22 to 319 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 298/329 (90 %) | 6 diff (98.2 %id) | |
BM453009 | leiomyosarcoma, uterus | .a | 430 to 812 | 443 to 833 | 391/970 (40 %) | 23 diff (97.7 %id) | |||
BM476696 | leiomyosarcoma, uterus | .a | 1 to 858 | 8 to 872 | 851/1115 (76 %) | 36 diff (96.8 %id) | |||
BM806248 | leiomyosarcoma, uterus | .a | 1605 to 2085 | 1 to 480 | AAA | 480/480 (100 %) | 2 diff (99.6 %id) | ||
BQ233581 | leiomyosarcoma, uterus | .a | 88 to 573 | 144 to 635 | 635/1280 (49 %) | 9 diff (99.3 %id) | |||
BM995677 | Chondrosarcoma, Left Pubic Bone | .a | 1421 to 2084 | 682 to 19 | AAA | 664/664 (100 %) | 1 diff (99.9 %id) | ||
BQ425406 | melanotic melanoma, skin | .a | 1 to 858 | 9 to 869 | tiling clone, | 869/882 (98 %) | 3 diff (99.7 %id) | ||
BU195785 | leiomyosarcoma, uterus | .e-u | 1 to 832 | 1 to 834 | C13L L14K F15Q V16S K18A ... | tiling clone, | 834/918 (90 %) | 59 diff (93.6 %id) | |
BU507911 | leiomyosarcoma, uterus | .a | 25 to 961 | 1 to 935 | 935/935 (100 %) | 7 diff (99.3 %id) | |||
BU943322 | mixed (pool of 40 RNAs) | .a | 1748 to 2079 | 1 to 332 | 332/332 (100 %) | 3 diff (99.1 %id) | |||
DR760167 | embryonic stem | .a | 384 to 1257 | 6 to 878 | 873/878 (99 %) | 6 diff (99.4 %id) | |||
DR763377 | embryonic stem | .a | 45 to 873 | 1 to 829 | 829/829 (100 %) | 0 diff (100 %id) | |||
CD557751 | testis | .a | 88 to 765 | 145 to 826 | 805/901 (89 %) | 13 diff (98.6 %id) | |||
DA609875 | .a | 88 to 525 | 127 to 564 | capped | 563/563 (100 %) | 2 diff (99.7 %id) | |||
DA612599 | .a | 88 to 539 | 134 to 585 | capped | 584/584 (100 %) | 0 diff (100 %id) | |||
DA618101 | .a | 88 to 536 | 126 to 574 | capped | 573/573 (100 %) | 2 diff (99.7 %id) | |||
TI_57170718 | .a | 88 to 678 | 171 to 762 | 710/1079 (65 %) | 9 diff (99.2 %id) | ||||
TI_57193356 | .a | 1351 to 1658 | 76 to 383 | AAA | 308/737 (41 %) | 11 diff (98.6 %id) | |||
N88235 | .a | -10 to 273 | 1 to 271 | 274/321 (85 %) | 28 diff (91.3 %id) | ||||
BP282259 | bone marrow | .a | 88 to 541 | 130 to 584 | 582/586 (99 %) | 8 diff (98.7 %id) | |||
BP283529 | bone marrow | .a | 88 to 549 | 137 to 598 | 598/598 (100 %) | 2 diff (99.7 %id) | |||
CB160181 | Liver | .a | 551 to 1168 | 1 to 618 | 618/618 (100 %) | 1 diff (99.9 %id) | |||
BP430527 | .a | 1 to 341 | 7 to 347 | 347/347 (100 %) | 4 diff (98.9 %id) | ||||
DA660346 | .a | 88 to 530 | 128 to 570 | capped | 569/569 (100 %) | 0 diff (100 %id) | |||
NM_006101.2 | .a | 88 to 2085 | 174 to 2171 | exact | RefSeq, AAA | 2171/2171 (100 %) | 0 diff (100 %id) | ||
DA730035 | .a | 88 to 765 | 128 to 804 | capped | 803/809 (99 %) | 2 diff (99.8 %id) | |||
AU129601 | .a | 88 to 738 | 122 to 786 | capped | 785/792 (99 %) | 15 diff (98.2 %id) | |||
AU151690 | .a | 1552 to 2078 | 526 to 1 | 526/575 (91 %) | 5 diff (99.2 %id) | ||||
DA815503 | .a | 88 to 528 | 128 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | |||
DA818180 | .a | 88 to 511 | 138 to 561 | capped | 560/560 (100 %) | 0 diff (100 %id) | |||
DA821790 | pericardium | .a | 88 to 539 | 104 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | ||
DA835740 | placenta | .a | 88 to 511 | 104 to 527 | capped | 526/526 (100 %) | 0 diff (100 %id) | ||
BM828736 | Ascites, stomach | .a | 88 to 539 | 122 to 573 | 573/573 (100 %) | 1 diff (99.9 %id) | |||
TI_1948139567 | .a | 95 to 767 | 128 to 801 | 674/1365 (49 %) | 13 diff (99.1 %id) | ||||
TI_1948139568 | .a | 95 to 1108 | 124 to 1135 | 1012/1195 (84 %) | 32 diff (97.4 %id) | ||||
TI_1948139569 | .a | 1110 to 2024 | 1044 to 125 | 920/1249 (73 %) | 22 diff (98.3 %id) | ||||
TI_1948139570 | .a | 95 to 679 | 128 to 715 | 588/1322 (44 %) | 23 diff (98.3 %id) | ||||
TI_1948139811 | .a | 95 to 764 | 125 to 795 | 671/1341 (50 %) | 19 diff (98.6 %id) | ||||
TI_1948139812 | .a | 95 to 1039 | 126 to 1081 | 954/1224 (77 %) | 38 diff (96.9 %id) | ||||
TI_1948139813 | .a | 1113 to 2024 | 1036 to 124 | 913/1189 (76 %) | 26 diff (97.9 %id) | ||||
TI_1948140072 | .a | 95 to 675 | 126 to 710 | 585/1360 (43 %) | 32 diff (97.7 %id) | ||||
TI_1948140074 | .a | 1166 to 2022 | 1002 to 127 | 876/1287 (68 %) | 37 diff (97.2 %id) | ||||
TI_1948140075 | .a | 95 to 678 | 127 to 715 | 589/1297 (45 %) | 34 diff (97.4 %id) | ||||
TI_1948140321 | .a | 95 to 804 | 126 to 839 | 714/1306 (54 %) | 14 diff (99.0 %id) | ||||
TI_1948140322 | .a | 1230 to 2024 | 919 to 124 | 796/1230 (64 %) | 16 diff (98.7 %id) | ||||
DA903159 | .a | 88 to 522 | 134 to 568 | capped | 567/567 (100 %) | 1 diff (99.9 %id) | |||
DA910990 | .a | 88 to 515 | 122 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | |||
DA911000 | .a | 88 to 524 | 122 to 559 | capped | 558/558 (100 %) | 1 diff (99.9 %id) | |||
DA912679 | .a | 88 to 493 | 162 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | |||
DA972092 | synovial membrane tissue from rheumatioidarthritis | .a | 88 to 539 | 122 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
DA983880 | synovial membrane tissue from rheumatioidarthritis | .a | 88 to 521 | 129 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DN998342 | bone marrow | .a | -10 to 640 | 1 to 651 | 651/651 (100 %) | 4 diff (99.4 %id) | |||
BM194061 | leukopheresis | .a | 88 to 405 | 148 to 465 | 465/466 (99 %) | 4 diff (99.2 %id) | |||
DB023753 | testis | .a | 88 to 475 | 147 to 534 | capped | 533/533 (100 %) | 0 diff (100 %id) | ||
DB035228 | testis | .a | 88 to 532 | 122 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | ||
DB035553 | testis | .a | 88 to 512 | 128 to 553 | capped | 552/552 (100 %) | 1 diff (99.9 %id) | ||
DB049418 | testis | .a | 88 to 496 | 156 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | ||
DB104211 | thymus | .b | 88 to 529 | 122 to 563 | tiling clone, capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
DB104879 | thymus | .a | 88 to 526 | 133 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DB109087 | thymus | .a | 88 to 522 | 129 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DB110276 | thymus | .a | 88 to 521 | 147 to 580 | capped | 579/579 (100 %) | 0 diff (100 %id) | ||
DB114163 | thymus | .a | -11 to 516 | 2 to 529 | capped | 528/528 (100 %) | 0 diff (100 %id) | ||
DB114313 | thymus | .a | -11 to 536 | 2 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | ||
DB116308 | thymus | .a | 88 to 500 | 130 to 542 | capped | 541/541 (100 %) | 1 diff (99.9 %id) | ||
DB121707 | thymus | .a | 88 to 520 | 135 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DB129955 | thymus | .a | 88 to 505 | 147 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DB130482 | thymus | .a | 88 to 493 | 133 to 538 | capped | 537/537 (100 %) | 0 diff (100 %id) | ||
TI_154106584 | .a | 1399 to 2085 | 773 to 88 | AAA | 686/687 (99 %) | 6 diff (99.2 %id) | |||
TI_154131255 | .a | 1236 to 2085 | 931 to 90 | AAA | 845/977 (86 %) | 25 diff (97.5 %id) | |||
BP369219 | testis | .a | 85 to 663 | 1 to 579 | 579/579 (100 %) | 3 diff (99.5 %id) | |||
CA311030 | Human Lung Epithelial cells, lung | .a | 1886 to 2085 | 218 to 19 | AAA | 200/333 (60 %) | 1 diff (99.7 %id) | ||
CA446863 | Chondrosarcoma, Left Pubic Bone | .a | 1447 to 2085 | 657 to 19 | AAA | 639/639 (100 %) | 0 diff (100 %id) | ||
BQ776118 | Bone, Human Chondrosarcoma Cell Line | .a | 1407 to 2085 | 697 to 19 | AAA | 679/679 (100 %) | 0 diff (100 %id) | ||
BU633554 | cell lines, Chondrosarcoma | .a | 1444 to 2085 | 659 to 19 | AAA | 641/641 (100 %) | 0 diff (100 %id) | ||
DB246622 | .a | 88 to 761 | 128 to 797 | capped | 797/844 (94 %) | 17 diff (98.0 %id) | |||
AV718036 | hypothalamus | .a | 88 to 536 | 126 to 574 | Suspected internal deletion, this clone was ignored | 573/573 (100 %) | 2 diff (99.7 %id) | ||
T89463 | liver and spleen | .a | 88 to 678 | 171 to 762 | This clone was ignored | 710/1079 (65 %) | 9 diff (99.2 %id) | ||
T89551 | liver and spleen | .a | 1351 to 1658 | 76 to 383 | This clone was ignored | 308/737 (41 %) | 11 diff (98.6 %id) | ||
AA911686 | pooled | .a | -10 to 273 | 1 to 271 | This clone was ignored | 274/321 (85 %) | 28 diff (91.3 %id) | ||
AI341285 | pooled germ cell tumors | .a | 88 to 541 | 130 to 584 | This clone was ignored | 582/586 (99 %) | 8 diff (98.7 %id) | ||
AI341287 | pooled germ cell tumors | .a | 88 to 549 | 137 to 598 | This clone was ignored | 598/598 (100 %) | 2 diff (99.7 %id) | ||
AI954614 | pooled germ cell tumors | .a | 551 to 1168 | 1 to 618 | This clone was ignored | 618/618 (100 %) | 1 diff (99.9 %id) | ||
AI955047 | pooled germ cell tumors | .a | 1 to 341 | 7 to 347 | This clone was ignored | 347/347 (100 %) | 4 diff (98.9 %id) | ||
BE503512 | pooled germ cell tumors | .a | 88 to 530 | 128 to 570 | This clone was ignored | 569/569 (100 %) | 0 diff (100 %id) | ||
BF001266 | colon, colon tumor, RER+ | .a | 88 to 2085 | 174 to 2171 | RefSeq, | Suspected internal deletion, this clone was ignored | 2171/2171 (100 %) | 0 diff (100 %id) | |
BQ776047 | Bone, Human Chondrosarcoma Cell Line | .a | 88 to 765 | 128 to 804 | AAA | Suspected internal deletion, this clone was ignored | 803/809 (99 %) | 2 diff (99.8 %id) | |
AU129601 | .a | 88 to 738 | 122 to 786 | capped | 785/792 (99 %) | 15 diff (98.2 %id) | |||
AU151690 | .a | 1552 to 2078 | 526 to 1 | 526/575 (91 %) | 5 diff (99.2 %id) | ||||
DA815503 | .a | 88 to 528 | 128 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | |||
DA818180 | .a | 88 to 511 | 138 to 561 | capped | 560/560 (100 %) | 0 diff (100 %id) | |||
DA821790 | pericardium | .a | 88 to 539 | 104 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | ||
DA835740 | placenta | .a | 88 to 511 | 104 to 527 | capped | 526/526 (100 %) | 0 diff (100 %id) | ||
BM828736 | Ascites, stomach | .a | 88 to 539 | 122 to 573 | 573/573 (100 %) | 1 diff (99.9 %id) | |||
BM828736 | Ascites, stomach | .a | 88 to 539 | 122 to 573 | 573/573 (100 %) | 1 diff (99.9 %id) | |||
TI_1948139567 | .a | 95 to 767 | 128 to 801 | 674/1365 (49 %) | 13 diff (99.1 %id) | ||||
TI_1948139568 | .a | 95 to 1108 | 124 to 1135 | 1012/1195 (84 %) | 32 diff (97.4 %id) | ||||
TI_1948139569 | .a | 1110 to 2024 | 1044 to 125 | 920/1249 (73 %) | 22 diff (98.3 %id) | ||||
TI_1948139570 | .a | 95 to 679 | 128 to 715 | 588/1322 (44 %) | 23 diff (98.3 %id) | ||||
TI_1948139811 | .a | 95 to 764 | 125 to 795 | 671/1341 (50 %) | 19 diff (98.6 %id) | ||||
TI_1948139812 | .a | 95 to 1039 | 126 to 1081 | 954/1224 (77 %) | 38 diff (96.9 %id) | ||||
TI_1948139813 | .a | 1113 to 2024 | 1036 to 124 | 913/1189 (76 %) | 26 diff (97.9 %id) | ||||
TI_1948140072 | .a | 95 to 675 | 126 to 710 | 585/1360 (43 %) | 32 diff (97.7 %id) | ||||
TI_1948140074 | .a | 1166 to 2022 | 1002 to 127 | 876/1287 (68 %) | 37 diff (97.2 %id) | ||||
TI_1948140075 | .a | 95 to 678 | 127 to 715 | 589/1297 (45 %) | 34 diff (97.4 %id) | ||||
TI_1948140321 | .a | 95 to 804 | 126 to 839 | 714/1306 (54 %) | 14 diff (99.0 %id) | ||||
TI_1948140322 | .a | 1230 to 2024 | 919 to 124 | 796/1230 (64 %) | 16 diff (98.7 %id) | ||||
DA903159 | .a | 88 to 522 | 134 to 568 | capped | 567/567 (100 %) | 1 diff (99.9 %id) | |||
DA910990 | .a | 88 to 515 | 122 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | |||
DA911000 | .a | 88 to 524 | 122 to 559 | capped | 558/558 (100 %) | 1 diff (99.9 %id) | |||
DA912679 | .a | 88 to 493 | 162 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | |||
DA972092 | synovial membrane tissue from rheumatioidarthritis | .a | 88 to 539 | 122 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
DA983880 | synovial membrane tissue from rheumatioidarthritis | .a | 88 to 521 | 129 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
DN998342 | bone marrow | .a | -10 to 640 | 1 to 651 | 651/651 (100 %) | 4 diff (99.4 %id) | |||
BM194061 | leukopheresis | .a | 88 to 405 | 148 to 465 | 465/466 (99 %) | 4 diff (99.2 %id) | |||
DB023753 | testis | .a | 88 to 475 | 147 to 534 | capped | 533/533 (100 %) | 0 diff (100 %id) | ||
DB035228 | testis | .a | 88 to 532 | 122 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | ||
DB035553 | testis | .a | 88 to 512 | 128 to 553 | capped | 552/552 (100 %) | 1 diff (99.9 %id) | ||
DB049418 | testis | .a | 88 to 496 | 156 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | ||
DB104211 | thymus | .b | 88 to 529 | 122 to 563 | tiling clone, capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
DB104879 | thymus | .a | 88 to 526 | 133 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DB109087 | thymus | .a | 88 to 522 | 129 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DB110276 | thymus | .a | 88 to 521 | 147 to 580 | capped | 579/579 (100 %) | 0 diff (100 %id) | ||
DB114163 | thymus | .a | -11 to 516 | 2 to 529 | capped | 528/528 (100 %) | 0 diff (100 %id) | ||
DB114313 | thymus | .a | -11 to 536 | 2 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | ||
DB116308 | thymus | .a | 88 to 500 | 130 to 542 | capped | 541/541 (100 %) | 1 diff (99.9 %id) | ||
DB121707 | thymus | .a | 88 to 520 | 135 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DB129955 | thymus | .a | 88 to 505 | 147 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DB130482 | thymus | .a | 88 to 493 | 133 to 538 | capped | 537/537 (100 %) | 0 diff (100 %id) | ||
TI_154106584 | .a | 1399 to 2085 | 773 to 88 | AAA | 686/687 (99 %) | 6 diff (99.2 %id) | |||
TI_154131255 | .a | 1236 to 2085 | 931 to 90 | AAA | 845/977 (86 %) | 25 diff (97.5 %id) | |||
BP369219 | testis | .a | 85 to 663 | 1 to 579 | 579/579 (100 %) | 3 diff (99.5 %id) | |||
CA311030 | Human Lung Epithelial cells, lung | .a | 1886 to 2085 | 218 to 19 | AAA | 200/333 (60 %) | 1 diff (99.7 %id) | ||
CA311030 | Human Lung Epithelial cells, lung | .a | 1886 to 2085 | 218 to 19 | AAA | 200/333 (60 %) | 1 diff (99.7 %id) | ||
CA446863 | Chondrosarcoma, Left Pubic Bone | .a | 1447 to 2085 | 657 to 19 | AAA | 639/639 (100 %) | 0 diff (100 %id) | ||
CA446863 | Chondrosarcoma, Left Pubic Bone | .a | 1447 to 2085 | 657 to 19 | AAA | 639/639 (100 %) | 0 diff (100 %id) | ||
BQ776118 | Bone, Human Chondrosarcoma Cell Line | .a | 1407 to 2085 | 697 to 19 | AAA | 679/679 (100 %) | 0 diff (100 %id) | ||
BQ776118 | Bone, Human Chondrosarcoma Cell Line | .a | 1407 to 2085 | 697 to 19 | AAA | 679/679 (100 %) | 0 diff (100 %id) | ||
BU633554 | cell lines, Chondrosarcoma | .a | 1444 to 2085 | 659 to 19 | AAA | 641/641 (100 %) | 0 diff (100 %id) | ||
BU633554 | cell lines, Chondrosarcoma | .a | 1444 to 2085 | 659 to 19 | AAA | 641/641 (100 %) | 0 diff (100 %id) | ||
DB246622 | .a | 88 to 761 | 128 to 797 | capped | 797/844 (94 %) | 17 diff (98.0 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e-u, .f, .g-u, .h | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DCI |